Instituto Alaxender Fleming

Site:	Instituto Alaxender Fleming
Address:
City:	Buenos Aires
State:
Zip:	C1426ANZ
Country:	Argentina

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors	Recruiting	Active, not recruiting	Bezuclastinib plus Sunitinib	NCT05208047